FIELD: medicine.
SUBSTANCE: intraoperationally introduced is fluoruracyl in dose 1000 mg/m and leukovorine in dose 100 mg/m after incubation with 100 ml of ozonised 400 mcg/l of autoblood intravenously. Oxaliplatin in dose 100 mg/m2 with 50 ml of ozonised 1000 mcg/l physiological solution is introduced into left gastric artery. Exposition of medications is 30 min. Gastrectomy is performed. After 7 days blood is sampled from patient in amount 100 ml in sterile vial with glugicir. Blood is bubbled. Concentration of ozone in ozone-oxygen mixture is 400 mcg/l. 100 mg/m2 of oxaliplatine are added and re-infused to patient intravenously, in drops. Next day 1000 mg/l of fluoruracyl and 100 mg/m2 of leukovorine are introduced successively intravenously, in drops with 100 ml of ozonised 400 mcg physiological solution. Treatment is repeated two times more with 3 week interval.
EFFECT: method makes it possible to prolong remission terms.
1 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF TREATING SIGNET-RING CELL CARCINOMA OF STOMACH | 2009 | 
 | RU2414890C1 | 
| METHOD OF TREATING NON-RESECTABLE SIGNET RING CELL ADENOCARCINOMA | 2010 | 
 | RU2438730C1 | 
| METHOD OF TREATING STOMACH CANCER | 2009 | 
 | RU2413472C1 | 
| METHOD OF ADJUVANT THERAPY OF LOCALLY ADVANCED STOMACH CANCER | 2011 | 
 | RU2465843C1 | 
| METHOD OF TREATING STOMACH CANCER | 2009 | 
 | RU2413310C1 | 
| METHOD FOR TREATING COLONIC CANCER | 2006 | 
 | RU2315568C1 | 
| METHOD OF MODIFIED CHEMICAL TREATMENT OF COLORECTAL CANCER | 2018 | 
 | RU2678642C1 | 
| METHOD OF CANCER OF RECTUM TREATMENT | 2007 | 
 | RU2352270C1 | 
| METHOD OF ORGAN-PRESERVING OPERATION IN CASE OF BREAST CANCER | 2008 | 
 | RU2361528C1 | 
| OESOPHAGEAL CARCINOMA THERAPY | 2007 | 
 | RU2356589C1 | 
Authors
Dates
2011-09-20—Published
2010-08-03—Filed